| Pharmaceutical Information |
| Drug Name |
Rimabotulinumtoxinb |
| Drug ID |
BADD_D01943 |
| Description |
Neurotoxin produced by fermentation of clostridium botulinum type B. The protein exists in noncovalent association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin complex. The neurotoxin complex is recovered from the fermentation process and purified through a series of precipitation and chromatography steps. |
| Indications and Usage |
For the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia. |
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB00042
|
| KEGG ID |
D02735
|
| MeSH ID |
C096323
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D02FXK
|
| NDC Product Code |
10454-711; 10454-712; 10454-710 |
| UNII |
0Y70779M1F
|
| Synonyms |
rimabotulinumtoxinB | rimabotulinum toxin B | rimabotulinumtoxin B | NeuroBloc | botulinum B toxin | botulinum toxin type B | botulinum neurotoxin B | Clostridium botulinum B toxin | Myobloc |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
93384-44-2 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
